| Entry |
|
|---|
| Name |
Mofegiline hydrochloride (USAN) |
|---|
| Formula |
C11H13F2N. HCl
|
|---|
| Exact mass |
233.0783
|
|---|
| Mol weight |
233.6854
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01512 Monoamine oxidase B inhibitor
|
|---|
| Efficacy |
Antiparkinsonian, Monoamine oxidase B (MAO-B) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01512 Monoamine oxidase B inhibitor
D03733 Mofegiline hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAOB
D03733 Mofegiline hydrochloride (USAN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C8x C 22.9600 -18.8300
2 C8y C 22.9600 -20.2300
3 C8x C 24.1724 -20.9300
4 C8x C 25.3849 -20.2300
5 C8y C 25.3849 -18.8300
6 C8x C 24.1724 -18.1300
7 X F 21.7476 -20.9300
8 C1b C 26.6160 -18.1190
9 C1b C 27.8124 -18.8300
10 C2c C 29.0249 -18.1300
11 C1b C 30.2373 -18.8300
12 N1a N 31.4497 -18.1300
13 C2b C 29.0249 -16.7302
14 X F 27.8313 -16.0410
15 X Cl 35.4200 -18.1300
BOND 14
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 5 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 10 13 2
14 13 14 1
|
|---|
